Reference

Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006;14:242-49.

Akerblad P, Lind U, Liberg D, Bamberg K, Sigvardsson M. Early B-cell factor (O/E-1) is

a promoter of adipogenesis and involved in control of genes important for terminal

adipocyte differentiation. Mol Cell Biol 2002;22:8015-25.

Ahmed M, Neville MJ, Edelmann MJ, Kessler BM, Karpe F. Proteomic analysis of

human adipose tissue after rosiglitazone treatment shows coordinated changes to promote

glucose uptake. Obesity (Silver Spring) 2010;18:27-34.

Ahn J, Lee H, Kim S, Ha T. Curcumin-induced suppression of adipogenic differentiation

is accompanied by activation of Wnt/β-catenin signaling. Am J Physiol Cell Physiol

2010;298: 1510-16.

Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped

BLAST and PSI-BLAST: a new generation of protein database search programs.

Nucleic Acids Res 1997;25:3389-402.

Amri EZ, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA. Cloning of a protein that

mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome

proliferator-activated receptors. J Biol Chem 1995;270:2367-71.

Ando C, Takahashi N, Hirai S. Luteolin, a food derived flavonoid, suppresses adipocyte-

dependent activation of macrophages by inhibiting JNK activation. FEBS Letters

2009;583: 3649–3654.

Aouadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binétruy B, Bost F. Inhibition of

p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 2006 ;

55:281-9.

Arita, Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura

I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara

79

K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an

adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun

1999.257: 79-83.

Bell A, Grunder L, Sorisky A. Rapamycin inhibits human adipocytes differentiation in

323 primary culture. Obes Res 2000;8:249–54.

Belmonte N, Phillips BW, Massiera F, Villageois P, Wdziekonski B, Saint-Marc P,

Nichols J, Aubert J, Saeki K, Yuo A, Narumiya S, Ailhaud G, Dani C. Activation of

extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of

CCAAT/enhancer binding proteins beta and -delta in preadipocytes. Mol Endocrinol

2001;15:2037-49.

Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD,

MacDougald OA. Regulation of Wnt signaling during adipogenesis. J Biol Chem

2002;277:30998−1004.

Berger J, Leibowitz MD, Doebber TW, Elbrecht A, Zhang B, Zhou G, Biswas C, Cullinan

CA, Hayes NS, Li Y, Tanen M, Ventre J, Wu MS, Berger GD, Mosley R, Marquis R,

Santini C, Sahoo SP, Tolman RL, Smith RG, Moller DE. Novel peroxisome proliferator-

activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological

effects. J Biol Chem 1999;274: 6718-6725.

Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53: 409-

35

Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role

in the development of metabolic syndrome and mitochondrial response to hypolipidemic

agents. J Obes 2011;2011:490650

Breer H, Boekhoff I, Tareilus E. Rapid kinetics of second messenger formation in

olfactory transduction. Nature 1990;345:65-8.

Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM.

80

Differential activation of adipogenesis by multiple PPAR isoforms.Genes Dev

1996;10:974-984.

Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during

adipose conversion of 3T3-L1 cells. Genes Dev 1991; 5: 1538-52.

Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis,

prediction, and natural course of HIV-1 proteaseinhibitor- associated lipodystrophy,

hyperlipidemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093-9.

Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. Peroxisome proliferator-

activatedreceptor (PPAR) gamma: adipose-predominant expression and induction early in

adipocyte differentiation. Endocrinology 1994;135: 798-800.

Chaerkady R, Harsha HC, Nalli A, Gucek M, Vivekanandan P, Akhtar J, Cole RN,

Simmers J, Schulick RD, Singh S, Torbenson M, Pandey A, Thuluvath PJ. A quantitative

proteomic approach for identification of potential biomarkers in hepatocellular

carcinoma. J Proteome Res 2008;7:4289-4298.

Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. Krox20 stimulates

adipogenesis via C/EBPbeta-dependent and -independent mechanisms.Cell Metab

2005;1:93-106

Cho KJ, Moon HE, Moini H, Packer L, Yoon DY, Chung AS. Alpha-lipoic acid inhibits

adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen

activated protein kinase pathways. J Biol Chem 2003;278:34823–33.

Cho HJ, Park J, Lee HW, Lee YS, Kim JB. Regulation of adipocytes differentiation and

insulin action with rapamycin. Biochem Biophys Res Commun 2004;321:942–8.

Cho EJ, Rahman MA, Kim SW, Baek YM, Hwang HJ, Oh JY, Hwang HS, Lee SH, Yun

JW. Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J Microbiol

Biotechnol 2008;18:80-7.

81

Choi S, Cha B, Lee Y, Yonezawa T, Teruya T, Nagai K, et al. Magnolol enhances

adipocytes differentiation and glucose uptake in 3T3-L1 cells. Life Sci 2009;84:908–14.

Christy RJ, Kaestner KH, Geiman DE, Lane MD. CCAAT/enhancer binding protein gene

promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc

Natl Acad Sci U S A 1991; 88: 2593-7.

Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat

regulation. Nature 1996;380: 677.

Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L.Endogenous glucose production is

inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001;108:1875-81.

Dagon Y, Avraham Y, Berry EM. AMPK activation regulates apoptosis, adipogenesis, and

lipolysis by eIF2alpha in adipocytes. . Biochem Biophys Res Commun 2006;340:43-7.

DiGirolamo M, Fine JB. Obesity. In: Branch WT Jr, Alexander RW, Schlant RC, Hurst J

(eds). Cardiology in Primary Care.McGraw-Hill: New York, 2000, pp 265–278.

Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z,

Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC. Erk Associates with and Primes

GSK-3-β for Its Inactivation Resulting in Upregulation of β –Catenin. Molecular Cell

2005 ;19:159–170.

Etherton TD.: The role of insulin-receptor interactions in regulation of nutrient utilization

by skeletal muscle and adipose tissue: a review. In: J Anim Sci 54 1982;1:58–67.

Fain JN, Bahouth SW, Madan AK. TNFα, alpha release by the nonfat cells of human

adipose tissue. Int J Obes Relat Metab Disord 2004;28:616-622.

Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4:4263–273.

Floyd ZE, Stephens JM. STAT5A promotes adipogenesis in nonprecursor cells and

associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes

82

2003 ;52:308-14.

Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature

1998;395:763-770.

Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer-binding

protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells.

Genes Dev 1994; 8: 1654-63.

Frühbeck G, Salvador J. Relation between leptin and the regulation of glucose

metabolism. Diabetologia 2000;43:3-12.

Gavrilova O, Marcus-Samuels B, Graham D. Surgical implantation of adipose tissue

reverses diabetes in lipoatropic mice. J.Clin.Invest 2000;105:271-278.

Gnudi L, Tozzo E, Shepherd PR, Bliss JL, Kahn BB. High level overexpression of

glucose transporter-4 driven by an adipose-speci.c promoter is maintained in transgenic

mice on a high fat diet, but does not prevent impaired glucose tolerance.Endocrinology

1995;136:995–1002.

Gregoire FM, Cynthia MS, Hei SS. Understanding adipocyte differentiation.

338 Physiol Rev 1998;78:783–809.

Grundy SM. Obesity, Metabolic Syndrome, and Cardiovascular Disease. J Clin

Endocrinol Metab 2004;89:2595–2600.

Guerre-Millo M. Adipose tissue and adipocytokines: for better or worse. Diabetes

Metab 2004;30:13–9.

Guo X, Liao K. Analysis of gene expression profile during 3T3-L1 preadipocyte

differentiation. Gene 2000;251:45-53.

Habinowski SA & Witters LA. The effects of AICAR on adipocyte differentiation of

3T3-L1 cells. Biochem Biophys Res Commun 2001;286:852–856.

83

Hamm JK, Park BH, Farmer SR. A role for C/EBPbeta in regulating peroxisome

proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1

preadipocytes. J Biol Chem 2001;276:18464-71.

Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E,. Shai I,

Kloting N, Stumvoll M, Bashan N, Rudich A. Macrophage infiltration into omental

versus subcutaneous fat across different populations: effect of regional adiposity and the

comorbidities of obesity. J Clin Endocrinol Metab2007;92:2240-2247.

Hassan M, Yassidi CE, Landrier JF, Lairon D, Margotat A, Amiot MJ. Phloretin enhances

adipocyte differentiation and adiponectin expression in 3T3-L1 cells. Biochem Biophys

Res Commun 2007;361:208–213.

Hintz KK, Aberle NS, Ren J. Insulin resistance induces hyperleptinemia, cardiac

contractile dysfunction but not cardiac leptin resistance in ventricular myocytes. Int J

Obes 2003;27:1196-1203.

Hirai S, Kim YI, Goto T. Inhibitory effect of naringenin chalcone on inflammatory

changes in the interaction between adipocytes and macrophages. Life Sci 2007;81: 1272–

1279.

Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, et al. IRS-1

independent defects define major nodes in insulin resistance. Cell Metab 2008;7:343 421-

33.

Hotamisligil GS, Shargill NS, Spiegelman BM.. Adipose expression of tumor necrosis

factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.

Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene

dysregulated in obesity. J Biol Chem 1996;271:10697-703.

Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ. Genistein, EGCG,

and capsaicin inhibit adipocyte differentiation process via activating AMP-activated

84

protein kinase. Biochem Biophys Res Commu 2005;338(2):694-9.

Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, Wendling O,

Mark M, Desvergne B, Wahli W, Chambon P, Metzger D. Peroxisome proliferator-

activated receptor gamma is required in mature white and brown adipocytes for their

survival in the mouse. Proc Natl Acad Sci U S A 2004; 101: 4543-7.

Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I.

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear

receptors. Diabetes 2003;52:1655–1663.

Itoh T, Fairall L, Amin K, Inaba Y, Szanto A, Balint BL, Nagy L, Yamamoto K, Schwabe

JW. Structural Basis for the Activation of Pparg by Oxidised Fatty Acids Nat Struct Mol

Biol 2008;15: 924-31.

Jones DT. GenTHREADER: an efficient and reliable protein fold recognition method for

genomic sequences. J Mol Biol 1999;287:797-815.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and

adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin

Invest 2006;116:1784–1792.

Kahn SE, Hull RL Kristina M. Utzschneider Mechanisms linking obesity to insulin

resistance and type 2 diabetes. Nature 2006;444:840-846.

Kajiya K, Inaki K, Tanaka M, Haga T, Kataoka H, Touhara K. Molecular bases of odor

discrimination: reconstitution of olfactory receptors that recognize overlapping

sets of odorants. J Neurosci 2001;21:6018–25.

Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor alpha-

induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for

suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 1995;

270: 23780 -84.

85

Kato Y, Ozaki N, Yamada T, Miura Y, Oiso Y. H-89 potentiates adipogenesis in 3T3-L1

cells by activating insulin signaling independently of protein kinase A. Life Sci

2007;80:476–83.

Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of

tumor necrosis factor in human adipose tissue. Regulation by obesity,weight loss, and

relationship to lipoprotein lipase. J Clin Invest 1995;95: 2111-2119.

Kershaw EE, Flier JS 2004. Adipose tissue as an endocrine organ. J Clin

Endocrinol Metab 89, 2548-56.

Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL,Yu

R. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and

associated with obesity-related parameters. Int J Obes.2005;30:1347-1355.

Kim JB, Spiegelman BM.. ADD1/SREBP1 promotes adipocyte differentiation and gene

expression linked to fatty acid metabolism. Genes Dev 1996;10:1096-1107.

Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPARgamma

through the production of endogenous ligand. Proc Natl Acad Sci U S A 1998;95:4333-7.

Kim JE, Chen J. Regulation of peroxisome proliferator-activated receptorgamma activity

by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes

2004;53:2748–56.

Kim KJ, Lee OH, Lee BY.Fucoidan, a sulfated polysaccharide, inhibits adipogenesis

through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Sci.

2010;86:791-7.

Kim YK, Choia HY, Kima NH, Lee W, Seoc D, Kanga D, et al. Reversine stimulates

adipocyte differentiation and downregulates Akt and p70s6k signaling pathways

in 3T3-L1 cells. Biochem Biophys Res Commun 2007;358:553–8.

Klemm DJ, Leitner JW, Watson P, Nesterova A, Reusch JE, Goalstone ML, Draznin B.

86

Insulin-induced adipocyte differentiation. Activation of CREB rescues adipogenesis from

the arrest caused by inhibition of prenylation. J Biol Chem. 2001 Jul 27;276(30):28430-5.

Epub 2001 May 25.

Konieczny SF, Emerson CP, Pairault J, Green H. A study of the adipose conversion

of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation

marker. Proc. Natl. Acad. Sci. 1979;76: 5138– 5142.

Konieczny SF, Emerson CP Jr. 5-Azacytidine induction of stable mesodermal stem cell

lineages from 10T1/2 cells. Cell 1984;38:791-800.

Lafontan M, Berlan M, Carpene C, Fat cell adrenoceptors: inter- and intraspecific

di_erences and hormone regulation. In: Int J Obes 9 Suppl 1 1985;117–127.

Lee J, Lee J, Jung E, Hwang W, Kim YS, Park D. Isorhamnetin-induced anti-adipogenesis

is mediated by stabilization of beta-catenin protein. Life Sci. 2010;86:416-23.

Lee J, Jung E, Lee J, Kim S, Huh S, Kim Y, Kim Y, Byun SY, Kim YS, Park D

Isorhamnetin represses adipogenesis in 3T3-L1 cells.Obesity (Silver Spring)

2009;17:226-32.

Lin FT, MacDougald OA, Diehl AM, Lane MD. A 30-kDa alternative translation product

of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking

antimitotic activity. Proc Natl Acad Sci U S A 1993; 90: 9606-10.

Linhart HG, Ishimura-Oka K, DeMayo F, Kibe T, Repka D, Poindexter B, Bick RJ,

Darlington GJ. C/EBPalpha is required for differentiation of white, but not brown,

adipose tissue. . Proc Natl Acad Sci U S A 2001;98:12532.

Liu Y, Zhang R, Xin J, Sun Y, Li J, Wei D, Zhao AZ. Identification of S100A16 as a

Novel Adipogenesis Promoting Factor in 3T3-L1 Cells. Endocrinology 2011;152:903-11.

Li Y, Lambert MH, Xu HE. Activation of nuclear receptors: a perspective from structural

genomics. Structure 2003; 11: 741-6.

87

Lowe G, Nakamura T, Gold GH. Adenylate cyclase mediates olfactory transduction for a

wide variety of odorants. Proc Natl Acad Sci U S A 1989;86:5641-5.

MacDougald OA, Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrinol

Metab 2002;13:5–11.

Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama

N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi

K, Horie M, Takeda S, Aoyama T, Funahashi T, and Matsuzawa Y. Diet-induced insulin

resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731-737.

Manning BD, Cantley LC. AKT/PK.B signaling: navigating downstream. Cell 2007;129:

1261–74.

Masuno H, Iwanami J, Kidani T, Sakayama K, Katsuhisa H. Bisphenol A Accelerates

Terminal Differentiation of 3T3-L1 Cells into Adipocytes through the

Phosphatidylinositol 3-Kinase Pathway. Toxicol Sci 2005;84:319–327.

Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, Christodoulides C, Perrin

C, Jimenez-Linan M, Blount M, Dixon J, Zahn D, Thresher RR, Aparicio S, Carlton M,

Colledge WH, Kettunen MI, Seppänen-Laakso T, Sethi JK, O'Rahilly S, Brindle K, Cinti

S, Oresic M, Burcelin R, Vidal-Puig A. The link between nutritional status and insulin

sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated

receptor-gamma2 isoform. Diabetes. 2005;54:1706-16.

Minokoshi Y, KimYB, Peroni OD, Fryer LG, Muller C, Carling D. Leptin stimulates

fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002;415:339-43.

Miyaoka Y, Tanaka M, Naiki T, Miyajima A. OncostatinMInhibits Adipogenesis through

the RAS/ERK and STAT5 Signaling Pathways. J Biol Chem 2006;281:37913-20.

Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S,

Coppack SW. Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor

Necrosis Factor-a, in Vivo. J Clinic End Metab 1997;82:4196-200.

88

Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J, Farmer SR.. Peroxisome-

proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during

adipogenesis. Biochem J 2003; 376: 607−613

Morrison RF, Farmer SR. Hormonal signaling and transcriptional control of adipocyte

differentiation. J Nutr 2000;130:3116–21.

Moran O, Phillip M. Leptin: obesity, diabetes and other peripheral effects – a review.

Pediatr Diabetes 2003;4:101-9.

Mueller E, Drori S, Aiyer A, Yie J, Sarraf P, Chen H, Hauser S, Rosen ED, Ge K, Roeder

RG, Spiegelman BM. Genetic analysis of adipogenesis through peroxisome proliferator-

activated receptor gamma isoforms. J Biol Chem 2002;277:41925-30.

Murugan V, Mukherjee K, Maiti K, Mukherjee PK. Enhanced oral bioavailability and

antioxidant profile of ellagic acid by phospholipids. J Agric Food Chem 2009;57: 4559-

65.

.Nagy L, Schwabe JW. Mechanism of the nuclear receptor molecular switch. Trends

Biochem Sci 2004; 29: 317-24.

Nanbu-Wakao R, Morikawa Y, Matsumura I, Masuho Y, Muramatsu MA, Senba E,

Wakao H. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of

transcription 5.Mol Endocrinol 2002;16:1565-76.

Nolte RT, Wisely GB, Westin S et al. Ligand binding and co-activator assembly of the

peroxisome proliferator-activated receptor-gamma. Nature 1998;395:137-43.

Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K, Nishimura G, Maemura K,

Yamauchi T, Kubota N, Suzuki R, Kitamura T, Akira S, Kadowaki T, Nagai R.Kruppel-

like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab.

1, 27–39 (2005).

Otto TC, Lane MD. Adipose development: from stem cell to adipocyte. Crit Rev Biochem

Mol Biol 2005;40:229-42.

89

Pace U, Hanski E, Salomon Y, Lancet D. Odorant-sensitive adenylate cyclase may

mediate olfactory reception. Nature 1985;316:255-8.

Park HS, Kim SH, Kim YS, Ryu SY, Hwang JT, Yang HJ, Kim GH, Kwon DY, Kim MS. Luteolin

inhibits adipogenic differentiation by regulating PPAR activation. Biofactors

2009;35:373-9

Park S, KimDS, Kang S. Gastrodia elata Blumewater extracts improve insulin resistance

by decreasing body fat in diet-induced obese rats: vanillin and 4-hydroxybenzaldehyde

are the bioactive candidates. Eur J Nutr 2010 [Epub ahead of print].

Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee

CH, Smith SA. Resistin is expressed in human macrophages and directly regulated by

PPAR gamma activators. Biochemical and biophysical research communications

2003;300:472-476

Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and Insulin Resistance. J Clin

Endocrinol Metab 2004;89:447-52.

Prusty D, Park BH, Davis KE, Farmer SR. Activation of MEK/ERK signaling promotes

adipogenesis by enhancing peroxisome proliferator-activated receptor gamma

(PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-

L1 preadipocytes. J Biol Chem 2002;277:46226–32.

Ren D, Collingwood TN, Rebar EJ, Wolffe AP, Camp HS. PPARgamma knockdown by

engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1

reactivates adipogenesis.Genes Dev 2002;16:27-32.

Reusch JE, Colton LA, Klemm DJ. CREB activation induces adipogenesis in 3T3-L1

cells. Mol Cell Biol 2000;20:1008-20.

Ribon V, Johnson JH, Camp HS, Saltiel AR. Thiazolidinediones and insulin resistance:

peroxisome proliferator activated receptor γ activation stimulates expression of the

90

CAP gene. Proc Natl Acad Sci U S A 1998:95:14751–14756.

Rojas J, Arraiz N, Aguirre M ,Velasco M, Berm´ udez V. AMPK as Target for Intervention

in Childhood and Adolescent Obesity. J Obes 201;2011:252817.

Ronti T, Lupattelli G, Monnarino E. The endocrine function of adipose tissue: an update.

Clin Endocrinol 2006; 64:355-65.

Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of

adipogenesis. Genes Dev 2000;14:1293–307

Rosen ED, Bruce M. Spiegelman PPAR γ: a nuclear regulator of metabolism,

differentiation, and cell growth. J Biol Chem 2001;276:37731–4.

Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ , Spiegelman

BM. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Genes Dev 2002;16:22-6.

Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol

Cell Biol 2006;7(12):885–96.

Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose

homeostasis. Nature 2006;444:847–53.

Rossini AA. Lipoatrophic diabetes. In: Marble A, Krall LP, Bradley RF, Christlieb AR,

Soeldner JS, eds. Joslin’s Diabetes Mellitus. 12th ed. Philadelphia: Lea & Febiger

1985;834 42.

Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL & MacDougald

OA. Inhibition of adipogenesis by Wnt signaling. Science 2000;289: 950−953.

Sakaue H, Ogawa W, Matsumoto M, Kuroda S, Takata M, Sugimoto T, et al.

Posttranscriptional control of adipocyte differentiation through activation of

phosphoinositide 3-kinase. J Biol Chem 1998;273:28945–52.

91

Sali A. and Blundell TL. Comparative Protein Modelling by Satisfaction of Spatial

Restraints. J Mol Biol 1993;234:779-815

Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M. Evaluation of comparative

protein modeling by MODELLER. Proteins 1995;23:318-26.

Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity andinsulin

resistance. Proc Natl Acad Sci 2003;100:7265-7270.

Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF,. A novel serum protein

similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270: 26746-49.

Schwarz EJ, Reginato MJ, Shao D et al. Retinoic acid blocks adipogenesis by inhibiting

C/EBPbeta-mediated transcription. Mol Cell Biol 1997; 17: 1552-61.

Seip M, Trygstad O. Generalized lipodystrophy, congenital lipodystrophy, congenital and

acquired (lipoatrophy). Acta Paediatr Suppl 1996;413:2-28.

Senn JJ, Klover PJ, Nowak IA, Mooney RA.Interleukin-6 Induces Cellular Insulin

Resistance in Hepatocytes. Diabetes 2002;51:3391-9

Sheu SH, Kaya T, Waxman DJ, Vajda S. Exploring the Binding Site Structure of the

PPARç Ligand-Binding Domain by Computational Solvent Mapping. Biochemistry

2005;44:1193-1209.

Shimba, S., Wada, T., Hara, S. & Tezuka, M. EPAS1 promotes adipose differentiation in

3T3-L1 cells. J Biol Chem 2004;279:40946-53

Shimba S, Ishii N, Ohta Y, Ohno T, Watabe Y, Hayashi M, Wada T, Aoyagi T, Tezuka M.

Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock,

regulates adipogenesis. Proc Natl Acad Sci U S A. 2005;102:12071-6

Sklar PB, Anholt RR, Snyder SH. The odorant-sensitive adenylate cyclase of olfactory

92

receptor cells. Differential stimulation by distinct classes of odorants. J Biol Chem

1986;261:15538-43.

Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM. Distinct transcriptional

profiles of adipogenesis in vivo and in vitro. J Biol Chem 2001;276:34167–74.

Spiegelman BM, Heinrich R. Biological control through regulated transcriptional

coactivators. Cell 2004;119:157-67.

Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor

agonist. Diabetes 2005;54:2460–2470.

Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM,

Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes.

Nature 2001;409: 307-312.

Sung HY, Kang SW, Kim JL, Li J, Lee ES, Gong JH, Han SJ, Kang YH Oleanolic acid

reduces markers of differentiation in 3T3-L1 adipocytes. Nutr Res 2010;30:831-9.

Sun K, Kusminski CM, Scherer PE. Adipose tissue remodelling in obesity. J Clin Invest

2011;121:2094-101.

Sypniewska G. Regulation of new fat cell formation. In: Acta Physiol Pol 40 1989;2:156–

163.

Tamori Y, Masugi J, Nishino N, Kasuga M. Role of peroxisome proliferator-activated

receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.

Diabetes 2002;51:2045-55.

Tanabe Y, Nakayama K. Nippon Yakurigaku Zasshi.Mechanical stretching inhibits

adipocyte differentiation of 3T3-L1 cells: the molecular mechanism and pharmacological

regulation Folia Pharmacologica Japonica Vol 2004;124:5337-344.

Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice

93

lacking the C/EBPbeta and/or C/EBPdelta gene. Embo J 1997;16:7432-43.

Tang QQ, Otto TC, Lane MD. CCAAT/ enhancer-binding protein β is required for mitotic

clonal expansion during adipogenesis. Proc. Natl Acad. Sci. USA 2003;100:850–855.

Tang QQ, Zhang JW, Daniel Lane M. Sequential gene promoter interactions by

C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. Biochem. Biophys.

Res. Commun 2004;318:213-218.

Taylor, SM., Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated

with 5-azacytidine. Cell 1979;17: 771– 779.

Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. Function of GATA

transcription factors in preadipocyte-adipocyte transition. Science. 2000;290:134-8.

Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS. Interaction between GATA and the

C/EBP family of transcription factors is critical in GATA-mediated suppression of

adipocyte differentiation. Mol Cell Biol 2005;25:706-15.

Tontonoz P, Kim JB, Graves RA, Spiegelman BM. ADD1: a novel helix-loop-helix

transcription factor associated with adipocyte determination and differentiation. Mol Cell

Biol 1993; 13: 4753-9.

Tontonoz PE, Hu RA, Graves AI, Budavari, Spiegelman BM. mPPAR gamma 2: tissue-

specific regulator of an adipocyte enhancer. Genes Dev 1994;8:1224-1234.

Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by

PPARγ2, a lipid activated transcription factor. Cell 1994;79:1147-56.

Torti FM, Torti SV, Larrick JW, Ringold GM. Modulation of adipocyte differentiation by

tumor necrosis factor and transforming growth factor beta. J Cell Biol 1989;108:

1105–13.

Trayhurn P, Duncan JS, Wood AM, Beattie JH. Regulation of metallothionein gene

94

expression and secretion in rat adipocytes differentiated from preadipocytes in primary

culture. Horm Metab Res. 2000;32:542-7.

Trayhurn P. Adipocyte biology Obes Rev 2007;8:Suppl 1:41-4.

Trayhurn P, Wang B, Wood IS. Hypoxia and the endocrine and signalling role of white

adipose tissue. Arch Physiol Biochem 2008;114:267-76.

Tusnády GE, Simon I. The HMMTOP transmembrane topology prediction server.

Bioinformatics 2001;17:849-50.

Tzameli I, Fang H, Ollero M, Shi H, Hamm JK, Kievit P, Hollenberg AN, Flier JS.

Regulated production of a peroxisome proliferator-activated receptor-gamma ligand

during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem

2004;279:36093-102.

Umesalma S, Sudhandiran G. Ellagic acid prevents rat colon carcinogenesis induced by

1, 2 dimethyl hydrazine through inhibition of AKT phosphoinositide -3 kinase

pathways.Eur J Pharmacol. 2011 (Ahead of Print).

Uppenberg J, Svensson C, Jaki M et al. Crystal structure of the ligand binding domain of

the human nuclear receptor PPARgamma. J Biol Chem 1998; 273: 31108-12.

Urso B, Cope DL, Kalloo-Hosein HE, et al. Differences in signaling properties of the

cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in

3T3–L1 adipocytes. J Biol Chem 1999;274:30864–30873

Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-

induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610-614.

Villena JA, Viollet B, Andreelli F, Kahn A, Vaulont S, Sul HS. Induced adiposity and

adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit.

Diabetes 2004;53:2242-9.

Wang Y, Porter WW, Suh N, Honda T, Gribble GW, Leesnitzer LM, et al. A synthetic

95

triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand

for the peroxisome proliferator-activated receptor {gamma}. Mol Endocrinol

2000;14:1550–6.

Wang Z, Hsieh TC, Zhang Z, Ma Y, Wu JM. Identification and purification of resveratrol

targeting proteins using immobilized resveratrol affinity chromatography. Biochem

Biophys Res Commun 2004;323:743-9.

Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an

endocrine mediator. Eur J Endocrinol 2000;143:293—311.

Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage

accumulation in adipose tissue J Clinic Invest 2003;112:1796-1808.

Welsh GI, Griffiths MR, Webster KJ, Page MJ, Tavaré JM. Proteome analysis of

adipogenesis. Proteomics 2004;4:1042–1051.

Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs: from orphan receptors to

drug discovery. J Med Chem 2000;43:527-5

Wood IS, Trayhurn P. Glucose transporter (GLUT and SGLT): expanded families of sugar

transport proteins. Br J Nutr 2003;89:3–9.

Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose Tissue: The New Endocrine

Organ? A Review Article. Dig Dis Sci 2008;54:1847-1856.

Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell

2006;124:471–84.

Wu Z, Rosen ED, Brun R et al. Cross-regulation of C/EBP alpha and PPAR gamma

controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell

1999; 3: 151-8.

Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami

96

K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L,

Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M,

Froguel P, Kadowaki T.. The fat-derived hormone adiponectin reverses insulin resistance

associated with both lipoatrophy and obesity. Nat Med 2001;7: 941-946.

Yang JY, Della-Fera MA, Hartzell DL, Nelson-Dooley C, Hausman DB, Baile CA.

Esculetin induces apoptosis and inhibits adipogenesis in 3T3-L1 cells. Obesity

2006;14:1691-9.

Yang JY, Della-Fera MA, Baile CA.Guggulsterone Inhibits Adipocyte Differentiation and

Induces Apoptosis in 3T3-L1 Cells. Obesity (Silver Spring) 2008;16:16-22.

Yang Y, Shang W, Zhou L, Jiang B, Jin H, Chen M. Emodin with PPAR γ ligand-binding

activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells.

Biochem Biophys Res Commun 2007;353:225-30.

Zhang J, Fu M, Cui T, Xiong C, Xu K, Zhong W, Xiao Y, Floyd D, Liang J, Li E, Song Q,

Chen YE. Selective disruption of PPARgamma 2 impairs the development of adipose

tissue and insulin sensitivity. Proc Natl Acad Sci U S A 2004;101:10703-8.

Zhang JW, Klemm DJ, Vinson C, Lane MD. Role of CREB in transcriptional regulation

of CCAAT/enhancer-binding protein beta gene during adipogenesis . J Biol Chem

2004;279:4471-8.

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning

of the mouse obese gene and its human homologue. Nature 1994;372: 425–432.

Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, et al. Structural organization of

mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene:

alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc

Natl Acad Sci 1995;92:7921-5.

Zou C, Shao J. Role of adipocytokines in obesity-associated insulin resistance. J Nutr

2007;137:2680–5.

97